Allison Bratzel

Stock Analyst at Piper Sandler

(4.85)
# 411
Out of 5,134 analysts
282
Total ratings
51.2%
Success rate
27.9%
Average return

Stocks Rated by Allison Bratzel

enGene Therapeutics
Nov 12, 2026
Upgraded: Buy
Price Target: $4
Current: $2.41
Upside: +65.98%
Scholar Rock Holding
Nov 11, 2026
Reiterated: Buy
Price Target: $75
Current: $43.21
Upside: +73.59%
Ionis Pharmaceuticals
Nov 9, 2026
Reiterated: Buy
Price Target: $87
Current: $29.06
Upside: +199.38%
Ultragenyx Pharmaceutical
Nov 5, 2026
Reiterated: Buy
Price Target: $36
Current: $16.08
Upside: +123.88%
ABIVAX Société Anonyme
Oct 21, 2026
Reiterated: Buy
Price Target: $175
Current: $87.58
Upside: +99.82%
Akebia Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $4
Current: $0.4742
Upside: +743.53%
Ardelyx
Oct 21, 2026
Reiterated: Buy
Price Target: $15
Current: $3.09
Upside: +385.44%
argenx SE
Oct 21, 2026
Reiterated: Buy
Price Target: $1,215
Current: $960.04
Upside: +26.56%
BioMarin Pharmaceutical
Oct 21, 2026
Reiterated: Buy
Price Target: $90
Current: $57.23
Upside: +57.26%
Codexis
Oct 21, 2026
Reiterated: Buy
Price Target: $8
Current: $1.16
Upside: +589.66%
Reiterated: Buy
Price Target: $130
Current: $120.97
Upside: +7.46%
Reiterated: Hold
Price Target: $49
Current: $44.46
Upside: +10.21%
Reiterated: Buy
Price Target: $68
Current: $50.65
Upside: +34.25%
Reiterated: Buy
Price Target: $56
Current: $20.03
Upside: +179.65%
Reiterated: Buy
Price Target: $4
Current: $1.04
Upside: +284.62%
Reiterated: Buy
Price Target: $30
Current: $13.82
Upside: +117.08%
Reiterated: Buy
Price Target: $52 → $55
Current: $28.56
Upside: +92.58%
Reiterated: Hold
Price Target: $1
Current: $0.5584
Upside: +79.08%
Reiterated: Buy
Price Target: $12
Current: $3.71
Upside: +223.45%
Reiterated: Buy
Price Target: $30
Current: $9.18
Upside: +226.80%
Reiterated: Buy
Price Target: $12
Current: $11.49
Upside: +4.44%
Reiterated: Buy
Price Target: $14
Current: $21.89
Upside: -36.04%
Downgraded: Hold
Price Target: $3 → $0.5
Current: $0.000001
Upside: +49,999,900.00%
Reiterated: Buy
Price Target: $22
Current: $39.53
Upside: n/a
Upgraded: Buy
Price Target: $8 → $20
Current: $6.84
Upside: n/a